Loading
Nanoecho AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 09 Jun 2025.
Nanoecho AB: what insiders have been doing
Nanoecho AB has a thin disclosure history in our data (latest filing: 9 June 2025). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€1,754
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleTord Evert Sigfried Labuda1 buy
Fundamental score
Ranked 20,663 of 24,148 companies
26.3
score / 100
Value1
Quality52
FCF yld-123%
Earn yld-116%
EV/EBITDA·
ROE-74%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.03
Analyst consensus
Income statement
RevenueSEK 488k
Gross profitSEK 488k100% margin
EBITDA-SEK 14.5M-2975% margin
Net income-SEK 15.7M-3207.8% margin
Valuation
P/Book0.8x
Beta0.64
Balance sheet & cash
Market capSEK 13.5M
Free Cash Flow-SEK 16.6M
Profitability & ownership
ROE-73.9%
ROA-38.7%
% insiders24.7%
% institutions3.9%
Last declaration on 9 June 2025
Declarations1 total
2,000,000 shares@ €0.00090.14% mcap100.0% of flowOptionFI:A003P454-1
Canonical exit: 2 Sept 2025 (T+90)
1 of 1 declaration
About Nanoecho AB
Nanoecho AB is a company focused on the healthcare and pharmaceutical sector, specializing in the development of innovative medical imaging technologies. It is listed on the Stockholm Stock Exchange (XSTO).
